FIRECREST Customer Support

Does the publication deadline match your timing? Sort over 10,000 journals and congresses by submission date and lead times using PubsHub Journals & Congresses. Find your optimum choices quickly so you can focus on your ...

Regulatory requirements continue to evolve across global markets. Keeping pace with changes from the FDA, EMA, MHRA, PMDA, NMPA and other health authorities is critical for successful product development and lifecycle ma...

Bringing APAC-developed therapies to global markets requires more than scientific innovation. It demands regulatory precision and informed decision making. Since 2021 APAC has led the world in clinical trial activity hig...

Strong teams aren't built in meeting rooms alone. More than 60 colleagues from our Dalian office in China recently stepped away from their desks to enjoy a day focused on collaboration, connection, and shared experience...

Continuous biomarkers offer a powerful opportunity to improve patient selection, yet defining the right cut-off remains a major challenge across diverse populations. Discover how developers are navigating these methodolo...

The fourth and final article in MedTech Insight’s PPWR series examines how medical device manufacturers can minimise packaging without compromising product protection, sterility or regulatory compliance. ICON regulatory...

Early-intervention MASLD trials require finding asymptomatic, high-risk patients at scale. However, conventional trial enrollment wasn't designed for that problem. Read the article to explore how prescreening protocols t...

Meet the ICON team at #CPHIMilan to learn how our integrated Manufacturing & Pharmacy Services can help you to accelerate development timelines, reduce outsourcing complexity, minimise API waste and move from formulation...

Need to accelerate recruitment for a challenging lactation study? In one recent study, ICON enrolled six participants within one week after recruitment had stalled elsewhere for more than a year. By combining targeted re...

Real-world data has the potential to deepen our understanding of patient outcomes in oncology, but only when analysed through a rigorous and transparent framework. Learn how ICON is helping bridge the gap between AI inno...

As obesity trials evolve, sponsors face growing protocol complexity, active comparator requirements and increasing competition for treatment-naïve participants. Join ICON experts to explore what these shifts mean for dev...

Join ICON at the 15th World CB & CDx Summit, 5 – 8 October in Boston. Meet our experts at booth \#4 to learn how ICON’s biomarker expertise drives smarter trials, accelerates CDx strategies & delivers patient impact. htt...